Celanese (CE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net sales were $2.7 billion, up 2% sequentially but down 5% year-over-year, with operating profit at $250 million and net earnings of $153–$155 million; diluted EPS was $1.41–$1.42, impacted by $102 million in shutdown and M&A-related costs.
Results reflect resilience and innovation amid significant external headwinds, including supplier outages, force majeure declarations, and weak demand.
The company continues to focus on deleveraging, cost optimization, and capital discipline following the M&M Acquisition and recent joint ventures.
Q3 guidance assumes stable market conditions with slight growth in auto builds, especially in China, and moderate volume growth from a strong product pipeline.
Margin growth expected from synergy capture and lower-cost raw materials, with no significant market improvement required beyond auto.
Financial highlights
Q2 2024 operating profit was $250 million; adjusted EBIT $451 million; operating EBITDA $632 million; gross profit $641 million on $2.7 billion in sales.
Force majeure in Acetyls resulted in a $35 million cost impact in Q2 and an additional $5–10 million expected in Q3.
Clear Lake productivity shortfall estimated at $40 million, with only half of the $100 million target expected this year.
Synergies for the first half were $40 million, expected to more than double in the second half to reach $150 million for the year.
Cash and cash equivalents were $1.19–$1.2 billion as of June 30, 2024; $500 million in debt repaid in Q2, with another $500 million targeted for Q3.
Outlook and guidance
Q3 and H2 2024 outlook assumes stable macro, moderate auto volume growth, and margin expansion from synergies and raw material cost pull-through.
Third quarter adjusted EPS expected between $2.75 and $3.00; full-year 2024 adjusted EPS guidance is $10.25–$10.75.
Fourth quarter expected to benefit from synergy capture, Clear Lake productivity, and less seasonality.
2025 expected to see continued self-help, additional M&M synergies, full Clear Lake productivity, and lower interest expense.
Free cash flow in 2025 expected to improve due to lower cash taxes, reduced interest, and stable CapEx.
Latest events from Celanese
- Board refreshment, pay-for-performance, and ESG oversight highlight this year's proxy.CE
Proxy Filing4 Mar 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, all board-backed.CE
Proxy Filing4 Mar 2026 - 2026 targets $650M–$750M free cash flow after strong 2025 cash generation and cost cuts.CE
Q4 202518 Feb 2026 - Q1 2025 net loss, cost cuts, and refinancing support $700–$800M free cash flow target.CE
Q1 20253 Feb 2026 - Q3 profit drop, 95% dividend cut, and cost actions target deleveraging amid weak demand.CE
Q3 202416 Jan 2026 - 2024 loss on $10.3B sales, but cost cuts and deleveraging set stage for 2025 recovery.CE
Q4 202417 Dec 2025 - Shareholders to vote on board refreshment, governance reforms, and executive pay amid strategic transformation.CE
Proxy Filing1 Dec 2025 - Board refreshment, governance reforms, and ESG integration drive strategic transformation.CE
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, compensation, and key governance changes.CE
Proxy Filing1 Dec 2025